Results 101 to 110 of about 15,690 (179)

Endocytic motif on HIV-1 Env regulates cleavage status and antibody neutralization of cell-free and cell-to-cell infection. [PDF]

J Virol
Figueroa Acosta DM, Valencia TR, Li H, Chen BK.   +3 more
europepmc   +1 more source

Genotypic and phenotypic characteristics of CXCR4-using transmitted/founder HIV-1 envelope glycoproteins. [PDF]

J Virol
Martres D, Montagné T, Pani S, Jeanne N, Armani-Tourret M, Requena M, Vellas C, Raymond S, Lorin V, Gallois Y, Puissant-Lubrano B, Mouquet H, Delobel P, Izopet J, Lagane B.   +14 more
europepmc   +1 more source

Comprehensive analysis of gp120 glycosylation to explore differences between transmitter/founder and chronic HIV-1 isolates. [PDF]

Glycobiology
Temesy S, Haly J, Sun Y, Patel M, Zebian N, Saha R, Galappaththi SL, Zhang Y, Twells N, Mahal LK, Arts EJ, Creuzenet C.   +11 more
europepmc   +1 more source

Framework-mediated binding of foreign and self-glycans by IGHV4-34 antibodies. [PDF]

Front Immunol
Langley DB, Jara CJ, Henry JY, Reed JH, Goodnow CC, Christ D.   +5 more
europepmc   +1 more source

Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV. [PDF]

J Infect Dis
Benlarbi M, Richard J, Clemente T, Bourassa C, Tolbert WD, Prakash M, Chandravanshi M, Clark A, Pazgier M, Durand M, Castagna A, Finzi A.   +11 more
europepmc   +1 more source

Allophycocyanin inhibits HIV-1 gp120 and reverse transcriptase through enthalpy-driven binding and antioxidative protection: integrative computational and experimental insights. [PDF]

Sci Rep
Dubey A, Kumar M, Tufail A, Anand K, Sengupta S.   +4 more
europepmc   +1 more source

Immunomagnetic Sample Preparation Targeting Host- and Viral-Derived Antigens for HIV-1 Isolation from Limited Plasma Volumes. [PDF]

Anal Chem
Gulati GK, Panpradist N, Lutz BR, Lai JJ.   +3 more
europepmc   +1 more source

N-Glycans modulate tilting of HIV-1 envelope glycoprotein. [PDF]

Nat Commun
Shehata M, Casalino L, Duquette M, Chen S, Flaherty A, Waller PM, Villa E, Amaro RE.   +7 more
europepmc   +1 more source

Human immunodeficiency virus vaccines: Advances, challenges and future perspectives. [PDF]

World J Virol
Varatharajan S, Krishnasai S, Girish C.
europepmc   +1 more source

Impact of cellular proteases on the function of antiviral antibodies. [PDF]

J Virol
Krzypow M, Schwartz O, Bruel T, Cottignies-Calamarte A.   +3 more
europepmc   +1 more source